ATE495271T1 - Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin - Google Patents
Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histaminInfo
- Publication number
- ATE495271T1 ATE495271T1 AT08786682T AT08786682T ATE495271T1 AT E495271 T1 ATE495271 T1 AT E495271T1 AT 08786682 T AT08786682 T AT 08786682T AT 08786682 T AT08786682 T AT 08786682T AT E495271 T1 ATE495271 T1 AT E495271T1
- Authority
- AT
- Austria
- Prior art keywords
- related disorders
- compositions
- methods
- detecting
- histamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07301286A EP2020446A1 (de) | 2007-07-31 | 2007-07-31 | Zusammensetzungen und Verfahren für den Nachweis von histaminbedingten Erkrankungen |
PCT/EP2008/060057 WO2009016231A2 (en) | 2007-07-31 | 2008-07-31 | Compositions and methods for detecting histamine related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE495271T1 true ATE495271T1 (de) | 2011-01-15 |
Family
ID=38859059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08786682T ATE495271T1 (de) | 2007-07-31 | 2008-07-31 | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100297631A1 (de) |
EP (2) | EP2020446A1 (de) |
AT (1) | ATE495271T1 (de) |
CA (1) | CA2695662A1 (de) |
DE (1) | DE602008004556D1 (de) |
WO (1) | WO2009016231A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12201676B2 (en) | 2011-03-18 | 2025-01-21 | Dr Healthcare España, S.L. | Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
ES2426539B1 (es) * | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
WO2021160696A1 (en) * | 2020-02-10 | 2021-08-19 | Immundiagnostik Ag | In-vitro diagnosis of histamine intolerance syndrome |
EP4134672A1 (de) * | 2021-08-09 | 2023-02-15 | Immundiagnostik AG | Differentialdiagnose bei einem histaminintoleranzsyndroms |
WO2023017050A1 (en) * | 2021-08-10 | 2023-02-16 | Immundiagnostik Ag | Differential diagnosis of histamine intolerance syndrome |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990010061A1 (en) * | 1989-03-02 | 1990-09-07 | Griffith University | Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals |
WO1997022002A1 (de) * | 1995-12-08 | 1997-06-19 | Reimann Hans Juergen | Verfahren und vorrichtung zur in-vitro diagnose allergischer erkrankungen |
US20050042630A1 (en) * | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
AT411688B (de) * | 2002-10-31 | 2004-04-26 | Jarisch Reinhard Dr | Verfahren zur bestimmung der aktivität von diaminooxidase |
US7772011B2 (en) * | 2005-03-21 | 2010-08-10 | Ronald Joseph Harbeck | Method and kit for detection of autoimmune chronic urticaria |
AT502850B1 (de) * | 2005-11-18 | 2007-08-15 | Albert Dr Missbichler | Verfahren zur bestimmung der aktivität von diaminooxidase |
-
2007
- 2007-07-31 EP EP07301286A patent/EP2020446A1/de not_active Withdrawn
-
2008
- 2008-07-31 WO PCT/EP2008/060057 patent/WO2009016231A2/en active Application Filing
- 2008-07-31 US US12/671,285 patent/US20100297631A1/en not_active Abandoned
- 2008-07-31 CA CA2695662A patent/CA2695662A1/en not_active Abandoned
- 2008-07-31 DE DE602008004556T patent/DE602008004556D1/de active Active
- 2008-07-31 EP EP08786682A patent/EP2183389B1/de active Active
- 2008-07-31 AT AT08786682T patent/ATE495271T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2183389B1 (de) | 2011-01-12 |
EP2020446A1 (de) | 2009-02-04 |
CA2695662A1 (en) | 2009-02-05 |
US20100297631A1 (en) | 2010-11-25 |
DE602008004556D1 (de) | 2011-02-24 |
EP2183389A2 (de) | 2010-05-12 |
WO2009016231A3 (en) | 2009-04-09 |
WO2009016231A2 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1117083A1 (en) | Compositions and methods for treatment of eye disorders | |
GB0421639D0 (en) | Methods and compositions relating to alzheimer's disease | |
ATE470151T1 (de) | Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern | |
EA201000644A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
MY164376A (en) | Phosphospecific antibodies recognizing tau | |
WO2008042231A3 (en) | Compositions and methods for evaluating and treating heart failure | |
WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
MY153198A (en) | Inhibitors of protein aggregation | |
BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
MX2009004705A (es) | Moleculas de enlace de albumina y usos de las mismas. | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
WO2007059064A3 (en) | Fgf2-related methods for diagnosing and treating depression | |
ATE485517T1 (de) | Verfahren zur identifizierung von polypeptid- targets | |
MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
TW200716172A (en) | Pharmaceutical compositions for treating lower motor neuron diseases | |
WO2010067078A8 (en) | 3,6-disubstituted xanthylium salts | |
MY150098A (en) | Benzylpiperazine derivates and their medical use | |
WO2009051718A3 (en) | Calcium receptor modulating agents | |
WO2006063093A3 (en) | Methods for diagnosis and treatment of crohn's disease | |
ATE495271T1 (de) | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin | |
EP1758605A4 (de) | Prouroguanylin als therapeutische und diagnostische mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |